基于斑马鱼模型研究琼胶寡糖改善酒精性脂肪肝的作用

Study on the effect of agaro-oligosaccharide in improving alcoholic fatty liver disease based on zebrafish model

  • 摘要: 目的: 基于斑马鱼模型探讨琼胶寡糖(AGOS)对酒精性脂肪肝(AFLD)的影响。方法: 将野生型AB品系斑马鱼分为正常组、模型组、水飞蓟宾组及AGOS低、中、高剂量组。除正常组给予系统水饲养,其余各组均给予1%酒精诱导斑马鱼AFLD模型。给药14 d后,采用苏木精—伊红(HE)染色、油红O染色观察肝组织病理变化,检测肝脏中丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、甘油三酯(TG)、总胆固醇(TC)、超氧化物歧化酶(SOD)、丙二醛(MDA)、还原型谷胱甘肽(GSH)水平,酶联免疫吸附试验(ELISA)法检测乙醇脱氢酶(ADH)、乙醛脱氢酶(ALDH)、细胞色素P4502E1(CYP2E1)、活性氧(ROS)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)含量。结果: 与正常组比较,模型组斑马鱼的肝细胞形态结构排列紊乱,出现明显脂肪变性,有大量脂肪沉积,肝组织ALT、AST、TG、TC、MDA、CYP2E1、ROS、IL-6、IL-1β、TNF-α水平升高,ALDH、SOD、GSH水平降低(均P<0.05);与模型组比较,水飞蓟宾组和AGOS各剂量组斑马鱼肝脏脂肪变性明显改善,脂肪沉积明显减少,肝组织ALT、AST、TG、TC、MDA、CYP2E1、ROS、IL-6、IL-1β、TNF-α水平降低,SOD水平升高(均P<0.05);水飞蓟宾组斑马鱼肝脏ADH、ALDH水平升高(均P<0.05);AGOS各剂量组GSH水平升高(均P<0.05)。结论: AGOS对斑马鱼AFLD具有一定的保护作用,其作用与调节脂质代谢、加速酒精代谢、减轻氧化应激和抑制炎症反应有关。

     

    Abstract: Objective: To investigate the effect of agaro-oligosaccharide (AGOS) on alcoholic fatty liver disease (AFLD) based on the zebrafish model. Methods: Wild type AB strain zebrafish were divided into normal group, model group, silibinin group, and AGOS low, medium and high dose groups. Except for the normal group given systemic water feeding, all the other groups were given 1% alcohol-induced zebrafish AFLD model. After 14 days of administration, the pathological changes in the liver tissue were observed by hematoxylin-eosin (HE) staining and Oil Red O staining, and the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), superoxide dismutase (SOD), malondialdehyde (MDA), and reduced glutathione (GSH) in the liver were detected. The contents of alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase (ALDH), cytochrome P4502E1 (CYP2E1), reactive oxygen species (ROS), interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay (ELISA). Results: Compared with the normal group, the morphological structure of the zebrafish hepatocytes was disordered, and there was obvious steatosis and a large amount of fat deposition in the model group. ALT, AST, TG, TC, MDA, CYP2E1, ROS, IL-6, IL-1β and and TNF-α levels in liver tissue were increased, and the levels of ALDH and SOD were decreased (all P<0.05). Compared with the model group, the silibinin group and AGOS dose groups had significantly improved the liver steatosis and reduced fat deposition in zebrafish. The levels of ALT, AST, TG, TC and MDA, CYP2E1, ROS, IL-6, IL-1β and TNF-α in liver tissue were decreased, and the level of SOD was increased (P<0.05). The ADH and ALDH levels in the liver of zebrafish in silibinin group were increased (all P<0.05), and the GSH levels in AGOS dose groups were increased (P<0.05). Conclusion: AGOS has a certain protective effect on zebrafish AFLD, which is related to regulating lipid metabolism, accelerating alcohol metabolism, alleviating oxidative stress and inhibiting inflammatory response.

     

/

返回文章
返回